Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...
While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...
The Cut on MSN8h
What We Actually Learned From RFK Jr.’s Confirmation HearingT he Senate confirmation hearings for noted conspiracy theorist and dead-animal enthusiast Robert F. Kennedy Jr. have finally ...
For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.
Health and Me on MSN10h
GLP-1 Drugs Affect 175 Health Conditions, Benefits Heart But Pose Risk To KidneysA new study has examined the effects of GLP-1 drugs on 175 different health outcomes. ​​​While these drugs have been found to ...
The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...
Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...
Recovery efforts underway after American Airlines flight collides with Army helicopter near DC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback